Joe Rogan

Joe Rogan is the host of the podcast The Joe Rogan Experience. The provided context does not list any academic background, field of study, or published research.

18 claims checked on air: 2 context 2 contradicted 5 supported 9 unverified 2 flagged

What they said on air - contradicted

0:56:50contradictedmoderateJoe Rogan Experience #2544 - Chris Williamson

Artificial intelligence models such as GPT-3 passed the Turing test.

"it already passed the Turing test quite a long time ago like like ChatGPT-3" (said at 0:56:50)

Empirical evaluations and philosophical assessments show that GPT-3 (and its successor GPT-3.5) did not pass the Turing test. In randomized, controlled Turing test experiments, GPT-3.5 was identified as human only ~20% of the time—performing on par with or worse than ELIZA (22%) and well below the human baseline (~66–67%). Earlier formal evaluations of base GPT-3 similarly showed that it routinely failed semantic questioning and tests of human-like intelligence. Only later models, such as GPT-4 and GPT-4o, have achieved pass rates approaching or matching human baselines in two-player Turing tests.

1:52:47contradictedmoderateJoe Rogan Experience #2544 - Chris Williamson

Retatrutide preserves muscle mass during weight loss.

"And then there's the retatrutide stuff. Am I saying that right? Retatrutide. Retatrutide. Retatu Retatrutide. That one is a weird one because that one allows you to keep muscle mass." (said at 1:52:47)

Clinical trial data contradict the claim that retatrutide preserves muscle mass or prevents muscle loss during weight reduction. In a Phase 2 randomized controlled trial substudy evaluating body composition via dual-energy X-ray absorptiometry (DXA), retatrutide produced substantial weight loss that included both fat mass and lean (fat-free/muscle) mass. The proportion of lean mass lost relative to total weight loss was consistent with typical weight loss and other incretin-based obesity medications, rather than sparing muscle mass.

Fact-checked episodes

Publications

No PubMed publication profile has been built for this speaker yet.